NCT05694169View on ClinicalTrials.gov

A Study of Participants With Chronic Kidney Disease Previously Treated With REACT

PHASE1TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

March 19, 2024

Study Completion Date

May 13, 2024

Conditions
Diabetic Kidney DiseaseCAKUTChronic Kidney Diseases
Interventions
BIOLOGICAL

Renal Autologous Cell Therapy (REACT)

Autologous selected renal cells (SRC)

Trial Locations (1)

83642

Boise kidney and Hypertension Institute, Boise

Sponsors

Lead Sponsor

Prokidney
All Listed Sponsors
lead

Prokidney

INDUSTRY